100% of our markets now operating on the new commercial model.
Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. Discover more about us below...
We invested £3.1 billion in 2015 in our search to develop new medicines, vaccines and consumer products.
We profiled around 40 new potential medicines and vaccines in our pipeline at our R&D event in 2015, 80% of which we believe are potentially first-in-class.
We have a network of 89 manufacturing sites, and large R&D centres in the UK, US, Belgium and China.
6 billion albendazole tablets donated to eliminate two neglected tropical diseases, reaching over 760 million people.
More than 11,000 people work in R&D in our search for new medicines, vaccines and consumer healthcare products.
In 2015, we distributed more than 690 million doses of vaccines around the world.
We employ around 101,000 people in over 100 countries, with more than a third of these in emerging markets.